Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17
ItalyStudy of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome
ItalyStudy on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn's Disease
ItalyStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
ItalyStudy of Mirikizumab for Children with Moderate to Severe Crohn's Disease
ItalyStudy on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant
ItalyStudy on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System
ItalyStudy of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer
ItalyStudy of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma
ItalyStudy on the Effects of Clodronate Disodium for Patients with Painful Knee Osteoarthritis
ItalyStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn's Disease
ItalyStudy on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn's Disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
